Highlights of the 16th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance

Journal of Cardiovascular Magnetic Resonance

Juliano Lara Fernandes³  Amit R Patel¹  John-Paul Carpenter² 

[1] University of Chicago, Chicago, USA;Royal Brompton Hospital, London, UK;University of Campinas, Campinas, Brazil

关键词: Heart;    Cardiovascular magnetic resonance;   

Others  :  812589
DOI  :  10.1186/1532-429X-15-60

 received in 2013-03-03, accepted in 2013-06-13,  发布年份 2013

【 摘 要 】

The 16th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR) took place in San Francisco, USA at the end of January 2013. With a faculty of experts from across the world, this congress provided a wealth of insight into cutting-edge research and technological development. This review article intends to provide a highlight of what represented the most significant advances in the field of cardiovascular magnetic resonance (CMR) during this year’s meeting.

【 授权许可】

   
2013 Carpenter et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Pennell DJ. Abstracts of the 16th annual SCMR scientific sessions. J Cardiovasc Magn Reson. 2013; 15 Suppl 1:1-481.
• [2]Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schonberg SO, Debl K, Strohm O, Ahlstrom H et al.. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial). J Cardiovasc Magn Reson. 2012; 14:61. BioMed Central Full Text
• [3]Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012; 14:63. BioMed Central Full Text
• [4]Mekkaoui C, Huang S, Chen HH, Dai G, Reese TG, Kostis WJ, Thiagalingam A, Maurovich-Horvat P, Ruskin JN, Hoffmann U et al.. Fiber architecture in remodeled myocardium revealed with a quantitative diffusion CMR tractography framework and histological validation. J Cardiovasc Magn Reson. 2012; 14:70. BioMed Central Full Text
• [5]Oshinski JN, Delfino JG, Sharma P, Gharib AM, Pettigrew RI. Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson. 2010; 12:55. BioMed Central Full Text
• [6]Snyder CJ, DelaBarre L, Metzger GJ, van de Moortele PF, Akgun C, Ugurbil K, Vaughan JT. Initial results of cardiac imaging at 7 Tesla. Magn Reson Med. 2009; 61:517-24.
• [7]Nielles-Vallespin S, Mekkaoui C, Gatehouse P, Reese TG, Keegan J, Ferreira PF, Collins S, Speier P, Feiweier T, de Silva R et al.. In vivo diffusion tensor MRI of the human heart: reproducibility of breath-hold and navigator-based approaches. Magn Reson Med. 2012; 12:17.
• [8]McGill LA, Ismail TF, Nielles-Vallespin S, Ferreira P, Scott AD, Roughton M, Kilner PJ, Ho SY, McCarthy KP, Gatehouse PD et al.. Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012; 14:86. BioMed Central Full Text
• [9]Ferreira PJ, Nielles-Vallespin S, Gatehouse PD, de Silva R, Keegan J, Speier P, Feiweier T, Reese TG, Ismail TF, Scott A et al.. Cardiac diffusion tensor imaging: helix angle (HA) healthy statistical average technique for HA quantification in vivo. J Cardiovasc Magn Reson. 2013; 15(suppl 1):W7.
• [10]Teh I, Lohezic M, Aksentijevic D, Schneider JE. Accelerated fast spin echo diffusion spectrum imaging in the mouse heart ex-vivo. J Cardiovasc Magn Reson. 2013; 15(suppl 1):W6. BioMed Central Full Text
• [11]Krug JW, Rose G, Stucht D, Clifford G, Oster J. Limitations of VCG based gating methods in ultra high field cardiac MRI. J Cardiovasc Magn Reson. 2013; 15(suppl 1):W19. BioMed Central Full Text
• [12]Tse Z, Dumoulin C, Watkins R, Butts Pauly K, Kwong RY, Michaud GF, Stevenson W, Joslesz F, Schmidt EJ. Improved cardiac gating at 3T with the “3D-QRS” method utilizing MRIcompatible 12-lead ECGs. J Cardiovasc Magn Reson. 2013; 15(suppl 1):W20. BioMed Central Full Text
• [13]Kahlert P, Parohl N, Albert J, Schafer L, Reinhardt R, Kaiser GM, McDougall I, Decker B, Plicht B, Erbel R et al.. Real-time magnetic resonance imaging-guided transarterial aortic valve implantation: in vivo evaluation in swine. J Am Coll Cardiol. 2012; 59:192-3.
• [14]Aneja A, Ono C, Scandling D, Jin N, Hinton AM, Pennell M, Raman SV, Simonetti OP. Left ventricular function, aortic velocity, and late gadolinium enhancement assessed by real-time and single shot CMR is comparable to breath-held segmented imaging: a prospective study. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O51. BioMed Central Full Text
• [15]Gamper U, Boesiger P, Kozerke S. Compressed sensing in dynamic MRI. Magn Reson Med. 2008; 59:365-73.
• [16]Schmidt M, Ekinci O, Liu J, Lefebvre A, Nadar MS, Mueller E, Zenge MO. Novel highly accelerated real-time CINE-MRI featuring compressed sensing with k-t regularization in comparison to TSENSE segmented and real-time Cine imaging. J Cardiovasc Magn Reson. 2013; 15(suppl 1):P36. BioMed Central Full Text
• [17]Jogiya R, Kozerke S, Morton G, De Silva K, Redwood S, Perera D, Nagel E, Plein S. Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease. J Am Coll Cardiol. 2012; 60:756-65.
• [18]Chen X, Salerno M, Epstein FH. Accelerated first-pass perfusion CMR using compressed sensing with regional spatiotemporal sparsity. J Cardiovasc Magn Reson. 2013; 15(suppl 1):E16.
• [19]Tsao J. Ultrafast imaging: principles, pitfalls, solutions, and applications. J Magn Reson Imaging. 2010; 32:252-66.
• [20]Sharif B, Dharmakumar R, Arsanjani R, Thomson LE, Merz NB, Berman DS, Li D. Ungated cine first-pass CMR for concurrent imaging of myocardial perfusion defects and wall motion abnormalities. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O1. BioMed Central Full Text
• [21]Yang Y, Feng X, Meyer CH, Kramer CM, Salerno M. First-pass myocardial perfusion imaging with whole ventricular coverage using L1-SPIRIT accelerated spiral trajectories. J Cardiovasc Magn Reson. 2013; 15(suppl 1):P20. BioMed Central Full Text
• [22]Petersson S, Sigfridsson A, Carlhall CJ, Ebbers T. Retrospectively gated intra-cardiac 4D flow CMR using spiral k-space trajectories. J Cardiovasc Magn Reson. 2013; 15(supll 1):O64.
• [23]Biglands JD, Radjenovic A, Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part II. J Cardiovasc Magn Reson. 2012; 14:66. BioMed Central Full Text
• [24]Sharif B, Dharmakumar R, LaBounty T, Shufelt C, Thomson LE, Merz NB, Berman DS, Li D. Eliminating dark-rim artifacts in first-pass myocardial perfusion imaging. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O3.
• [25]Wu Y, Yang F, Chung Y-C. Robust and fast SSFP for the evaluation of LV function at 3T. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O52. BioMed Central Full Text
• [26]Rothstein T, Camargo GC, Quintella DC, Fernandes E, Strecker R, Greiser A, Derenne ME, Lima M, Moojen JJ, Rizzi PB et al.. Artifact suppression of SSFP cine sequences at 3T using a novel automatic 3D shimming algorithm. J Cardiovasc Magn Reson. 2013; 15(suppl 1):P57. BioMed Central Full Text
• [27]White SK, Sado DM, Flett AS, Moon JC. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart. 2012; 98:773-9.
• [28]Fitts M, Breton E, Kholmovski E, Dosdall DJ, Vijayakumar S, Hong KP, Ranjan R, Marrouche NF, Axel L, Kim D. Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O112. BioMed Central Full Text
• [29]Slavin GS, Stainsby JA. True T1 mapping with SMART1Map (saturation method using adaptive recovery times for cardiac T1 mapping): a comparison with MOLLI. J Cardiovasc Magn Reson. 2013; 15(suppl 1):P3.
• [30]Piechnik SK, Ferreira VM, Dall’Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 And 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010; 12:69. BioMed Central Full Text
• [31]Henningsson M, Botnar RM, Voigt T. 3D saturation recovery imaging for free breathing myocardial T1 mapping. J Cardiovasc Magn Reson. 2013; 15(suppl 1):P44.
• [32]Biglino G, Verschueren P, Zegels R, Taylor AM, Schievano S. Rapid prototyping compliant arterial phantoms for in-vitro studies and device testing. J Cardiovasc Magn Reson. 2013; 15:2. BioMed Central Full Text
• [33]Acevedo-Bolton G, Saloner D. Using MRI derived patient-specific flow models and flow imaging for flow diverting stent rehearsal. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O56.
• [34]Jiji RS, Pollak AW, Epstein FH, Antkowiak PF, Meyer CH, Weltman AL, Lopez D, Dimaria JM, Hunter JR, Christopher JM, Kramer CM. Reproducibility of rest and exercise stress contrast-enhanced calf perfusion magnetic resonance imaging in peripheral arterial disease. J Cardiovasc Magn Reson. 2013; 15:14. BioMed Central Full Text
• [35]Clement-Guinaudeau S, Topel ML, Ali A, Poole JC, Rocco E, Khan SA, Zhong X, Epstein FH, Kramer CM, Quyyumi AA, Oshinski JN. MR-based calf muscle perfusion index correlates with treadmill exercise test parameters in patients with peripheral arterial disease. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O58. BioMed Central Full Text
• [36]Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, Nothnagel D, Steen H, Petersen S, Nagel E et al.. European cardiovascular magnetic resonance (EuroCMR) registry - multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson. 2013; 15:9. BioMed Central Full Text
• [37]Andre F, Celik C, Abdel-Aty H, Santos MFB, Giannitsis E, Katus H, Steen H. Comparison of parameters for left ventricular volumes and function between echocardiography and cardiovascular magnetic resonance in a large group of cardiac patients. J Cardiovasc Magn Reson. 2013; 15(suppl 1):E74. BioMed Central Full Text
• [38]Joshi SB, Connelly KA, Jimenez-Juan L, Hansen M, Kirpalani A, Dorian P, Mangat I, Al-Hesayen A, Crean AM, Wright GA et al.. Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation. J Cardiovasc Magn Reson. 2012; 14:69. BioMed Central Full Text
• [39]Wong TC, Piehler K, Puntil KS, Moguillansky D, Meier CG, Lacomis JM, Kellman P, Cook SC, Schwartzman DS, Simon MA et al.. Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson. 2013; 15:6. BioMed Central Full Text
• [40]Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P et al.. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation. 2011; 124:1351-60.
• [41]Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ et al.. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012; 379:453-60.
• [42]Greenwood JP, Walker S, Giardin F, McKenna C, Everett C, Nixon J, Brown J, Plein MS. Cost-effectiveness of magnetic resonance imaging in coronary heart disease: an economic evaluation using data from the CE-MARC study. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O7. BioMed Central Full Text
• [43]Kelle S, Petrov G, Kern S, Fleck E, Wellnhofer E. Cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in stable coronary artery disease - a post-hoc analysis. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O8. BioMed Central Full Text
• [44]Genders TS, Petersen SE, Pugliese F, Dastidar AG, Fleischmann KE, Nieman K, Hunink M. Stress myocardial perfusion cardiac magnetic resonance imaging vs. coronary CT angiography in the diagnostic work-up of patients with stable chest pain: comparative effectiveness and costs. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O9.
• [45]Plein S, Herzog BA, Maredia N, Kidambi A, Motwani M, Uddin A, Ripley DP, Dickinson CJ, Brown J, Nixon J et al.. The ischaemic and scar burden measured by cardiac magnetic resonance imaging in patients with ischaemic coronary heart disease from the CE-MARC study. J Cardiovasc Magn Reson. 2013; 15(suppl1):O105.
• [46]Manka R, Gebker R, Wissmann L, Jogiya R, Motwani M, Frick M, Reinartz SD, Schnackenburg B, Nagel E, Plein S, Kozerke S. Multicenter evaluation of dynamic three-dimensional whole-heart myocardial perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O103.
• [47]Parsai C, O’Hanlon R, Prasad SK, Mohiaddin RH. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson. 2012; 14:54. BioMed Central Full Text
• [48]Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2012; 14:13. BioMed Central Full Text
• [49]Ismail TF, Jabbour A, Gulati A, Mallorie A, Raza S, Cowling TE, Das B, Khwaja J, Wage R, Moon J et al.. Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O67. BioMed Central Full Text
• [50]Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, Abraham TP, Ho C, Bluemke DA. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012; 14:17. BioMed Central Full Text
• [51]Deva DP, Williams LK, Care M, Siminovitch KA, Moshonov H, Wintersperger BJ, Rakowski H, Crean AM. Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O33. BioMed Central Full Text
• [52]Flett A, Maestrini V, Milliken D, Fontana M, Harb R, Sado D, Quarta G, Herrey AS, Elliott P, McKenna WJ, Moon J. A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O36. BioMed Central Full Text
• [53]Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD et al.. Identification and assessment of anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial t1 mapping. Circ Cardiovasc Imaging. 2013; 6:392-8.
• [54]Simpson R, Keegan J, Firmin D. Efficient and reproducible high resolution spiral myocardial phase velocity mapping of the entire cardiac cycle. J Cardiovasc Magn Reson. 2013; 15:34. BioMed Central Full Text
• [55]Alexandre J, Saloux E, Dugue AE, Lebon A, Lemaitre A, Roule V, Labombarda F, Provost N, Gomes S, Scanu P, Milliez P. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson. 2013; 15:12. BioMed Central Full Text
• [56]Leyva F, Foley PW, Chalil S, Ratib K, Smith RE, Prinzen F, Auricchio A. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011; 13:29. BioMed Central Full Text
• [57]Tse Z, Dumoulin C, Byrd I, Schweitzer J, Watkins R, Pauly KB, Kwong RY, Michaud GF, Stevenson W, Jolesz F, Schmidt EJ. Voltage-based electroanatomic mapping system for MR-guided cardiac electrophysiology: preliminary swine validations. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O88. BioMed Central Full Text
• [58]Ramanan V, Celik H, Ghate S, Barry J, Ghugre NR, Leber V, Stainsby JA, Shmatukha A, Shurrab M, Crystal E, Wright G. Exploring intrinsic MR signal relaxation in acute RF ablation lesions using T2 mapping and IR-SSFP CINE imaging. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O87. BioMed Central Full Text
• [59]Ainslie M, Miller CA, Brown B, Davidson N, Fox DJ, Schmitt M. Multiparametric CMR assessment of RV apical versus septal Pacing Study (MAPS) - preliminary acute hemodynamic findings. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O85. BioMed Central Full Text
• [60]Muzzarelli S, Monney P, O’Brien K, Faletra F, Moccetti T, Vogt P, Schwitter J. Quantification of aortic valve regurgitation by phase-contrast magnetic resonance in patients with bicuspid aortic valve: where to measure the flow? J Cardiovasc Magn Reson. 2013; 15(suppl 1):O37. BioMed Central Full Text
• [61]Hart C, Gabbert DD, Voges I, Jerosch-Herold M, Andrade A, Pham M, Hansen T, Kramer H-H, Rickers C. New insights in the Fontan circulation: 4-dimensional respiratory- and ECG-triggered phase contrast magnetic resonance imaging. J Cardiovasc Magn Reson. 2013; 15(suppl 1):O38.
• [62]Markl M, Kilner PJ, Ebbers T. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011; 13:7. BioMed Central Full Text